Klin Farmakol Farm. 2009;23(4):166-170

Systemic oral enzyme therapy after lumbar disc herniation surgery

Lubomír Pekař1, Jiří Steindler2
1 Neurochirurgická klinika FN Královské Vinohrady v Praze
2 Oddělení neurochirurgie FN Motol v Praze

The aim of this open pilot observation was to prove the influence of the long-term oral systemic enzyme therapy (SE) on subjectively

perceived pain, disabilities caused by back pain and development of late postoperative complications after lumbar disc herniation

surgery.

Patients after lumbar disc herniation surgery (n = 100; aver. age 41,99 year, SD ±9,06) were randomly divided into two groups. All patients

were administered by analgesics and underwent physiotherapy after surgery. The SE group (n = 50, aver. age = 41,24 year, SD ±9,86) was

administered by combined enzyme preparation Phlogenzym (bromelaina 90 mg, trypsinum 48 mg rutosid 100 mg), besides the usual

post-operative treatment. The control group KO (n = 50, aver. age = 42,74 year, SD ±9,39) underwent obligatory treatment only.

Preoperative and postoperative status was evaluated according to Visual Analog Scale (VAS), Roland-Morris questionnaire (RMQ) and

Oswestry Disability Index (ODI). Subjective evaluation of improvement, development of failed back surgery syndrome (FBSS) and ability

to work after surgery were other objectives of the follow-up. Statistical evaluation of the results was accomplished.

Statistically significant differences between individual groups were proved for the benefit of the SE group in subjectively perceived

pain (VAS, p = 0,025), disability for lower back pain (RMQ, p = 0,0006) and in the difference of the patients’ disabilities in common daily

activities (ODI, p = 0,023).

The difference in late postoperative surgery complication occurrence was close to the significance level (p = 0,08). No difference in the

influence of SE therapy on the ability to work (p = 0,68) was found.

This follow-up results are stimulating for continuing research of SE as supportive treatment for patient after lumbar disc herniation surgery.

Keywords: lumbar disc disease, postoperative treatment, failed back surgery syndrome, systemic oral enzyme therapy

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pekař L, Steindler J. Systemic oral enzyme therapy after lumbar disc herniation surgery. Klin Farmakol Farm. 2009;23(4):166-170.
Download citation

References

  1. Mazanec D, Okereke L. Interpreting the Spine Patient Outcomes Research Trial. Medical vs surgical treatment of lumbar disk herniation: implications for future trials. Cleve Clin J Med 2007; 74(8): 577-583. Go to original source... Go to PubMed...
  2. Legrand E, Bouvard B, Audran M, Fournier D, Valat JP. Sciatica from disk herniation: Medical treatment or surgery? Joint Bone Spine 2007; 74(6): 530-535. Go to original source... Go to PubMed...
  3. Yukawa Y, Kato F, Ito K, Terashima T, Horie Y. A prospective randomized study of preemptive analgesia for postoperative pain in the patients undergoing posterior lumbar interbody fusion: continuous subcutaneous morphine, continuous epidural morphine, and diclofenac sodium. Spine 2005; 30(21): 2357-2361. Go to original source... Go to PubMed...
  4. Hans P, Brichant JF, Bonhomme V, Triffaux M. Analgesic efficiency of propacetamol hydrochlorid after lumbar disc surgery. Acta Anaesthesiol Belg 1993; 44(4): 129-133. Go to PubMed...
  5. Jezdinský J. Systémová enzymoterapie. In: Lincová D, Farghali H (ed.). Základní a aplikovaná farmakologie, 2. vydání, Praha, Galén, 2007.
  6. Klein G, Kullich W, Schnitker J, Schwann H. Efficacy and olerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 2006; 24: 25-30. Go to PubMed...
  7. Wittenborg A, Bock PR, Hanisch J, Saller R, Schneider B. Comparative epidemiological study in patients with rheumatic diseases illustrated in an example of a treatment with non-steroidal anti-inflammatory drugs versus an oral enzyme combination. Drug Research, 2000; 50(II): 728-738. Go to original source... Go to PubMed...
  8. Heidland A, Sebekova K, Paczek L, Teschner M, Dämmrich J, Gaciong Z. Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. Kidney Int Suppl. 1997; 62: S32-S35. Go to PubMed...
  9. Heyll U, Munnich U, Ziegenhagen DJ, Senger V. Development and current status of non-specific enzyme therapy. Versicherungsmedizin 2003; 55(4): 163-170. Go to PubMed...
  10. Rahn HD. Begleitende Therapie durch hydrolytische Enzyme bei arthroskopischer Meniskuresektion. Prakt. Sport-Traumatologie und Sportmedizin 1994; 10(3): 123-127.
  11. Duskova M, Wald M. Orally administered proteases in aesthetic surgery. Aesthetic Plast Surg 1999; 23(1): 41-44. Go to original source... Go to PubMed...
  12. Beuth J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients-results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol 2001; 47 Suppl: S45-S54. Go to original source... Go to PubMed...
  13. Kameníček V, Holaň P, Franěk P. Systémová enzymoterapie v léčbě a profylaxi protraumatických a pooperačních otoků. Acta Chir Orthop Traumatol Cech. 2001; 68(1): 45-49. Go to PubMed...
  14. Phlogenzym - Summary of product characteristics. MUCOS Pharma GmbH & Co. http://www.sukl.cz/download/spc/SPC96176.doc.
  15. Ohnhaus EE, Adler R. Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 1975; 1(4): 379-384. Go to original source... Go to PubMed...
  16. Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8(2): 141-144. Go to original source... Go to PubMed...
  17. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000; 25(22): 2940-2952. Go to original source... Go to PubMed...
  18. Weinstein JN, Lurie JD, Tosteson TD, Tosteson AN, Blood EA, Abdu WA, et al. Surgical versus nonoperative treatment for lumbar disc herniation: four-year results for the Spine Patient Outcomes Research Trial (SPORT). Spine 2008; 33(25): 2789-2800. Go to original source... Go to PubMed...
  19. Postacchini F. Management of herniation of the lumbar disc. J Bone Joint Surg Br 1999; 81(4): 567-576. Go to original source... Go to PubMed...
  20. Hazard RG. Failed back surgery syndrome: surgical and nonsurgical approaches. Clin Orthop Relat Res 2006; 443: 228-232. Go to original source... Go to PubMed...
  21. Chrobok J, Vrba I, Stetkarova I. Selection of surgical procedures for treatment of failed back surgery syndrome (FBSS). Chir Narzadow Ruchu Ortop Pol 2005; 70(2): 147-153. Go to PubMed...
  22. Dimar JR, Ante WA, Zhang YP, Glassman SD. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 1996; 21(16): 1870-1876. Go to original source... Go to PubMed...
  23. Ostelo RW, Costa LO, Maher CG, de Vet HC, van Tulder MW. Rehabilitation after lumbar disc surgery. Cochrane Database Syst Rev 2008; (4): CD003007. Go to original source...
  24. Rooney BA, Crown ED, Hulsebosch CE, McAdoo DJ. Preemptive analgesia with lidocaine prevents Failed Back Surgery Syndrome. Exp Neurol 2007; 204(2): 589-596. Go to original source... Go to PubMed...
  25. Ozer AF, Oktenoglu T, Sasani M, Bozkus H, Canbulat N, Karaarslan E, et al. Preserving the ligamentum flavum in lumbar discectomy: a new technique that prevents scar tissue formation in the first 6 months postsurgery. Neurosurgery 2006; 59(1 Suppl 1): ONS126-ONS133. Go to original source... Go to PubMed...
  26. Fransen P. Safety of carboxymethylcellulose/polyethylene oxide for the prevention of adhesions in lumbar disc herniation - consecutive case series review. Ann Surg Innov Res 2008; 2: 2. Go to original source... Go to PubMed...
  27. Nouza K, Nouza M. Zánět optimalizující a imunonormalizační účinky kombinací proteolytických enzymů. Alergie 2002; 4: 326-329.
  28. Wood GR, Ziska T, Morgenstern E, Studer G. Sequential effects of an oral enzyme combination with rutosid in different in vitro and in vivo models of inflammation. Int J Immunotherapy 1997: XIII(3/4): 139-145.
  29. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today. 1990; 11(5): 163-166. Go to original source... Go to PubMed...
  30. Desser L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I. Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Cancer Chemother Pharmacol 2001; 47 Suppl: S10-S15. Go to original source... Go to PubMed...
  31. Lauer D, Muller R, Cott C, Otto A, Naumann M, Birkenmeier G. Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy. Cancer Chemother Pharmacol 2001; 47 Suppl: S4-S9. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.